Advancing Extrahepatic RNAi Delivery to Improve Targeting Selectivity Across Obesity, Metabolic, Cardiovascular, Neurology & Oncology
After major pharma investments, billion-dollar partnerships, and promising clinical progress has launched the RNAi field into a new era of growth, the 8th RNAi-Based Therapeutics Summit returns to unite the leaders driving this momentum to explore the next frontier of RNAi development. As the field focuses on overcoming its biggest challenge of extra-hepatic delivery across high-value indications like neurology, cardiometabolic disease, obesity, cardiovascular disease, and oncology, this summit provides the platform for decision-makers to come together and work together in interactive workshops, hear from experts in panels, and explore new data from our expert speakers.
RNAi's Latest News:
Explore the Full Event Guide
- Learn from 20+ expert speakers from leading biotech and pharma companies including Eli Lilly, Bayer, Thalia Therapeutics, & Canary Cure
- Explore the newest insights into data covering extrahepatic RNAi delivery, CNS, cardiovascular, obesity, retinal & oncology applications, as well as applications of miRNA technology
- Gain practical insights into funding, partnerships & clinical translation strategies
- Create connections with top RNAi decision-makers through dedicated networking sessions with 80+ industry leaders
Expert RNAi Speakers Included:
Official Partners
Attending Companies Included
Explore the Agenda
Discover the latest advances in extrahepatic delivery, RNAi chemistry, CNS targeting and chronic disease applications.
Partner With Us
Showcase your capabilities to RNAi developers seeking solutions for delivery, manufacturing and clinical translation.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.